Robshaw & Julian Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $3.08M | Sell |
43,460
-50
| -0.1% | -$3.54K | 2.2% | 25 |
|
|
2017
Q1 | $2.96M | Buy |
43,510
+8,000
| +23% | +$543K | 2.13% | 25 |
|
|
2016
Q4 | $2.54M | Buy |
35,510
+1,925
| +6% | +$138K | 1.88% | 28 |
|
|
2016
Q3 | $2.66M | Buy |
33,585
+2,200
| +7% | +$174K | 1.97% | 27 |
|
|
2016
Q2 | $2.62M | Buy |
31,385
+670
| +2% | +$55.9K | 2% | 26 |
|
|
2016
Q1 | $2.82M | Buy |
30,715
+300
| +1% | +$27.6K | 2.13% | 25 |
|
|
2015
Q4 | $3.08M | Buy |
30,415
+700
| +2% | +$70.8K | 2.38% | 23 |
|
|
2015
Q3 | $2.91M | Buy |
29,715
+900
| +3% | +$88.1K | 2.46% | 23 |
|
|
2015
Q2 | $3.37M | Buy |
28,815
+725
| +3% | +$84.9K | 2.59% | 23 |
|
|
2015
Q1 | $2.77M | Buy |
28,090
+1,005
| +4% | +$99.1K | 2.08% | 24 |
|
|
2014
Q4 | $2.55M | Buy |
27,085
+2,800
| +12% | +$264K | 2.01% | 23 |
|
|
2014
Q3 | $2.59M | Buy |
24,285
+780
| +3% | +$83K | 2.04% | 22 |
|
|
2014
Q2 | $3.01M | Buy |
23,505
+4,625
| +24% | +$592K | 2.31% | 23 |
|
|
2014
Q1 | $1.34M | Buy |
+18,880
| New | +$1.34M | 1.03% | 33 |
|